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Abstract: A chromatographic and densitometic method for identification and quantitative determination of 
4 ,4-bis[4-(p-chlorophenyl)—4~hydroxypiperidino]butyrophenone as an impurity in haloperidol pharmaceutical 
has been developed. The HPTLC plates and chloroform -m ethanol-am m onium  hydroxide 25% (90:9:1) were 
used for chromatographic separation as stationary and mobile phases respectively. Detection has been carried 
out in UV at X=350 nm. The determination could be made directly without preliminary component separation 
by extraction. Based on the statistical analysis of obtained results, it was found that the new method is accurate 
and repeatable.
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4 ,4 -b is [4 - p - c h lo ro p h e n y l)^ f -h y d ro x y p ip e r i -  
d in o ]b u ty ro p h en o n e  (Z H ) b e lo n g s to  b u ty ro p h en o - 
ne  d e riv a tiv es  w h ich  sh o w s sim ila rity  in ch em ica l 
co m p o sitio n , th u s a lso  in  p h y sica l and  ch em ica l 
p ro p erties , to  n eu ro lep tic  ag en ts  u sed  in m ed ical 
trea tm en t (1). P a rtic u la r  sim ila rity  ap p lies  to h a lo ­
p erid o l (PB F ) w h ich  is u sed  fo r trea tm en t o f  
sch izo p h ren ia , m an iac  sta te  an d  in an aesth es io lo g y  
fo r p rem ed ica tio n  (2 ).
A n a lo g ie s  in ch em ica l c o m p o s itio n s  an d  s im i­
larity  in p h y sica l an d  ch em ica l p ro p e rtie s  im p ed e  
th e  ev a lu a tio n  o f  h a lo p e rid o l p u rity . T h is  p ro b lem  
has been  in c lu d ed  in to  o ffic ia l p ro c ed u re s  fo r 
ha lo p erid o l p u rity  ev a lu a tio n  g iv en  in A m erican  (3) 
and E u ro p ean  (4) p h a rm aco p o e ias , w h ere  U V  sp ec­
tro p h o to m e try  is u sed  to  d e te rm in e  Z H  in su b stan ce  
by using  d iffe ren ces  in ab so rp tio n  sp e c tra  fo r  im ­
p u ritie s  and  PB F .
H alo p erid o l is u se d  in m ed ica l trea tm en t in 
v a rio u s p h a rm aceu tica l fo rm s such  as tab le ts , in jec ­
tio n s and  d ro p s c o n ta in in g  a lso  so m e ad d itiv es 
w h ich  can  im p ed e  sp e c tro p h o to m etric  d e te rm in a ­
tion . T h ere fo re , it is n ecessa ry  to  search  fo r new  
m eth o d s a llo w in g  d e te rm in a tio n  o f  Z H  in h a lo p e ri­
dol p h a rm aceu tica ls .
A cco rd in g  to  th e  p ro v en  lite ra tu re , n u m ero u s 
m eth o d s have  b een  e m p lo y e d  in an a ly sis  o f  4 - f lu o -  
ro b u ty ro p h en o n  d e riv a tiv e s  co m m e n c in g  from  
th in - la y e r  ch ro m a to g ra p h y  (5 -9 ) ,  th ro u g h  gas 
c h ro m a to g rp h y  (10, 12) to  H P L C  (1 3 -1 5 )  and  
e lec tro ch em ica l m eth o d s (16 , 17).
T h is  p a p e r  p re se n ts  a  new  c h ro m a to g ra p h ic
an d  d e n s ito m e tr ic  m e th o d  d e v e lo p e d  fo r id e n ­
tif ic a tio n  o f  Z H  in h a lo p e rid o l ta b le ts ,  in je c tio n s  
an d  d ro p s . T h e  se p a ra tio n  an d  d e te c tio n  c o n d i­
tio n s  w ere  c h o se n  to  e n a b le  u s  d irec t d e te rm in a ­
tio n  w ith o u t u s in g  u n n e c e ssa ry  e x tra c tio n  p ro c e ­
d u re s  h a v in g  an  e ffe c t on  te s t d u ra tio n  a n d  re su lt 
re lia b ility .
EXPERIMENTAL
A p p ara tu s, so lu tio n s , reag en ts
T h e  K iese lg e l 60  F 254  H P T L C  -  A lu fo lien  
p la te s  o f  a lu m in iu m  fo il c o a ted  w ith  s ilic a  gel 
m an u fac tu red  by  M erck  w ere  used . D en sito m e tric  
an a ly sis  w as c a rried  ou t on  T C  S can er 3 d e n ­
sito m e te r w ith  C a ts  4  so ftw a re  d e v e lo p ed  by  C a- 
m ag  (S w itzerlan d ). L in o m a t IV  w as used  to  app ly  
sp e c im en s  from  th e  sam e m an u fac tu re r.
T h e  so lu tio n s w ere  p rep ared  by d isso lv in g  
a p p ro p ria te  w e ig h ed  sam p le s  in  th e  m ix tu re  o f  
ch lo ro fo rm  and  m eth an o l ( 1 : 1  v /v).
R e fe ren ce  so lu tions:
-  4 ,4 - b i s [4 - p - c h lo r o p h e n y l ) - 4 - h y d r o x y p ip e r id i -  
n o jb u ty ro p h e n o n e  (U .S .P .C . Inc ., R o ck v ille , M D ), 
so lu tio n s  fro m  4 0  p g /m l to  180 p g /m l.
-  H a lo p erid o l s tan d ard  (U S P  23), so lu tio n  238 
p g /m l.
T es t so lu tions:
T ab le ts : (Po lfa , s. 10989, 2 0 8 9 8 ) co n ta in in g  
1 m g o f  h a lo p e rid o l an d  (N eu rax p h am  A rzn eim it- 
tel, s. 942 0 1 3 ) co n ta in in g  4  m g o f  h a lo p e rid o l. 5 ml
23
24 JAN KRZEK and ANNA MAŚLANKA
o f  c h lo ro fo rm -m e th an o l m ix tu re  w as ad d ed  to  p o ­
w dered  tab le ts  o f  w e igh t co rresp o n d in g  to  10 m g o f  
ha loperido l. A fter 1 5 -m in u te  shak ing  the  suspension  
w as cen trifu g ed  an d  su p ern atan t w as co llected . T he 
so lu tion  50  p i, w as ap p lied  on  each  plate.
In jec tio n s: (P o lfa , s. 3 0 4 9 8 ) co n ta in in g  5 m g 
o f  h a lo p e rid o l in 1 m l so lu tio n . T h e  so lu tio n  20  p i, 
w as ap p lied  on  each  p la te .
Drops: (m anufacturer: Z F A  U nia, s. 60989, 
20989) contain ing 2 m g o f  haloperidol in 1 ml o f  
solution. T esting  w as carried  out d irectly  by applying 
50 pi o f  solution on p lates and  afte r extracting  5 ml o f  
solution w ith th ree  ch loroform  doses, 5 m l each. T he 
com bined  chloroform  ex tracts w ere  sub jected  to va­
cuum  evaporation . T he residue w as d issolved in 2 ml 
o f  ch lo ro fo rm -m ethano l m ix ture  (1:1 v/v). T he solu­
tion 20 p i w as app lied  on  each  plate.
H a lo p erid o l su b s tan ce  (P o lfa), a  so lu tio n  c o n ­
ta in in g  5 .5 6  m g o f  h a lo p erid o l in 1 m l o f  c h lo ro ­
fo rm -m e th a n o l m ix tu re  (1:1 v /v).
R eag en ts : M erck  reag en ts  o f  c h ro m a to g ra p h ic  p u ri­
ty w ere  used .
D e te rm in a tio n  c o n d itio n s
D iffe ren t v o lu m es o f  re le v an t re fe ren ce  and  
tes t so lu tio n s w e re  a p p lied  on  p la te s  by  lin o m at to 
ob ta in  c h ro m a to g ram s in m o b ile  p h ases  at p a th  o f  
8 cm  -  20  cm  in leng th . C h ro m ato g ram s w ere  d ried  
at ro o m  tem p era tu re  an d  th en  su b je c ted  to  d en - 
sito m e tric  ana ly sis .
A s a resu lt, o p tim u m  co n d itio n s  fo r  c h ro m a to ­
g rap h ic  se p a ra tio n  o f  Z H  o c cu rre d  as im p u ritie s  in 
h a lo p erid o l and  m eth o d  fo r its d e tec tio n  w ere  
e s tab lish ed .
D e te rm in a tio n  p ro ced u re
T h e  re fe ren ce  so lu tions, 10 p i each , and  test 
so lu tions in ap p ro p ria te  vo lum es, a s  d ec rib ed  above, 
w ere ap p lied  by linom at in 15 m m  bands on plates 
o f  12x10 cm  in size. C h ro m ato g ram s w ere  d ev elo ­
ped on the  p a th  o f  10 cm  by using  a  m o b ile  phase  
se lec ted  ex p erim en tally : c h lo ro fo rm -m e th an o l-am - 
m on ium  hydrox ide  25%  (90:9:1 v /v). A fte r d ry in g  at 
room  tem p era tu re , th e  ch ro m a to g ram s w ere  reco r­
ded d en sito m etrica lly  in U V  a t X=350 nm.
T h e  sp o ts  on  ch ro m a to g ra m s w ere  in d en tif ied  
by  co m p a rin g  R f v a lu es fo r  re fe ren ce  a n d  tes ted  
so lu tio n s , w h e reas its co n ten ts  w as c a lcu la te d  on 
a co m p u te r by  c o m p arin g  ap p ro p ria te  p eak  areas.
RESULTS AND DISCUSSION
In  o rd e r  to  f in d  fa v o u ra b le  c o n d it io n s  fo r  
c h ro m a to g ra p h ic  s e p a ra t io n  o f  Z H , th e  H P T L C  
p la te s  o f  h ig h  re s o lu tio n  w e re  u se d  as s ta tio n a ry
p h a se  th a t  e n a b le d  u s  to  se p a ra te  Z H  fro m  P B F  
by  u s in g  a  m o b ile  p h a se  c h o se n  e x p e r im e n ta l ly :  
c h lo ro fo rm -m e th a n o l-a m m o n iu m  h y d ro x id e  25%  
(90:9:1 v /v).
A  d e n s i to m e tr ic  a n a ly s is  o f  th e  re la tio n s h ip  
b e tw e e n  a b so rb a n c e  a n d  w a v e le n g th  (A=f(A .)) 
r e v e a le d  a  c h a ra c te r is tic  a b so rp tio n  b a n d  w ith  
m a x im u m  in  U V  a t ^.=350  n m  fo r  Z H , w h ile  in 
th e  c a s e  o f  P B F  th e  c h a ra c te r is tic  a b so rp tio n  
b a n d  r e a c h e d  its  m a x im u m  a t A.=249 nm . T h e  fa c t 
th a t  a t A.=350 n m  o n ly  Z H  a b so rb a n c e  is  o b s e r ­
v e d  a llo w s  s e le c tiv e  d e te rm in a tio n  o f  Z H  a n d  
P B F  (F ig u re  1).
A s a  re su lt o f  th is  a n a ly s is  th e  sp o t loca tio n s 
on  th e  ch ro m a to g ram s w ere  e s tb lish e d  fo r  P B F  (R f 
- 0 .9 1 )  and  Z H  (R f -0 .7 6 ) .  T h ese  re su lts  h av e  been  
c o n firm ed  by sta in  reac tio n  w ith  th e  D ra g en d o rff  
re ag e n t (18).
It is im p o rtan t fo r  id en tif ic a tio n  an d  q u a n ­
tita tiv e  d e te rm in a tio n  that, u n d e r sp e c if ied  c h ro m a ­
to g rap h ic  se p a ra tio n  co n d itio n s an d  d en sito m e tric  
d e tec tio n  co n d itio n s , w ell d e v e lo p ed  a n d  sy m m et­
rica l p eak s a re  o b ta ined .
A n  e x am p le  o f  c h ro m a to g ram  an d  den sito - 
g ram  is p re sen te d  in F ig u re  2.
T h e  v a lid a tio n  o f  new ly  d e v e lo p ed  m eth o d  
has b een  ca rried  o u t by  th e  d e te rm in a tio n  o f  its 
d e tec tab ility , lin ea rity  an d  accu racy .
B ased  o n  a se rie s  o f  d ilu tio n s , th e  m in im u m  
d e te c ta b le  co n cen tra tio n  o f  Z H  w as fo u n d  to  be
1.25 p g /m l a n d  its d e te rm in ab ility  a t th e  leve l o f  
2.5 p g /m l.
T h e  lin e a r re la tio n sh ip  b e tw een  th e  p eak  a rea  
and  co n ce n tra tio n  w ith in  the  co n ce n tra tio n  ran g e  
u n d e r in v es tig a tio n  (2 .5  |ig /m l to  4 0  p g /m l)  is 
p re sen te d  in  F ig u re  3.
T o  v e rify  th e  accu racy  o f  th e  n ew ly  d e v e lo p ed  
m eth o d , a  m odel m ix tu re  c o n ta in in g  3 .2 0  m g  o f  Z H
[nm]
Figure 1. UV spectra obtained densitometrically for appropriate 
chromatograms: PBF (I )  and ZH (2).
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F ig u re  2 . A  c h r o m a to g r a m  a n d  d e n s i to g ra m  r e c o r d e d  a t  X = 3 5 0  
nm  f o r  Z H  (1 )  a n d  P B F  (2 ) .  T h e  s p o t  s iz e  a n d  lo c a t io n  on  
c h ro m a to g r a m  w e re  c o n f i r m e d  b y  s ta in in g  w i th  D r a g e n d o r f f  
r e a g e n t .
in 100 m l o f  c h lo ro fo rm -m e th a n o l m ix tu re  (1:1 
v /v) w as p rep ared . It w as fo u n d  th a t, fo r n = 5 , the  
Z H  co n ten ts  x = 3 .5 8  m g, S x= 0 .2 7  an d  t0,9s=  ± 0 .3 3 . 
T h e  re su lts  w e  o b ta in ed , co n firm  th e  h ig h  se n ­
s itiv ity  an d  d e te rm in ab ility  o f  th e  new  m eth o d  an d  
g u a ran tee  its a ccu racy  a n d  rep ea tab ility .
T h e  u sab ility  o f  th is  m e th o d  has b een  v e rified  
by  d e te rm in in g  Z H  co n ten ts  in  p h a rm a ce u tic a ls  o f  
v a rio u s fo rm s c o m in g  fro m  d o m estic  and  fo re ig n  
m an u fac tu re rs . T h e  re su lts  a re  p re sen te d  in  T ab le  1.
C o rre la tio n : r =  0 .9 9 1 7 6
c [Mg/ml] 
R egress io n  9 5 %  co n fid .
F ig u re  3. P e a k  a re a  v s . Z H  c o n c e n tr a t io n .









Drops 2 mg/ml 
after extraction
Drops 2 mg/ml 
without extraction
S.B34233005/97 s. 10898 s.942013 s.30498 s.60898 s.60898
7.48-102 5.65-10'2 4.23-10 '2 5.35-102 1.57-1 O'2 8.69-102
9.20-1 O'2 5.69-102 4.33-10'2 5.50-10 '2 1.85-102 8.64-10 '2
9.70-102 5.57-10‘2 4.34-10 '2 5.13-1 O'2 2.00-10‘2 9.71-102
8.20-1 O'2 5.17-10 '2 4.40-10-2 5.33-1 O’2 1.72-10‘2 9.60-102
8.00-102 5.58-102 3.84-10‘2 5.44-10‘2 1.92 1 0 2 8.50-10'2
x=8.52-10'2 x=5.53-10'2 x=4.14-102 x=5.35-10'2 x=l .81-102 x=8.31-10'2
S„=0.9-10'2 Sx= 0 .2110 '2 Sx=0.22-102 Sx=0.14-10- Sx= 0 .1710 '2 Sx=0.58-102
t=±1.13 10 2 t=+0.26-10'2 t=±0.27-10'2 t=± 0 .18-102 t=±0.21 • 1 O'2 t=±0.72-102
s.20898 s.20898 s.20898
5.10-10"2 1.81-10 '2 7.6.7-102
5.16-102 1.96 10 2 7.73-10 '2
4.62-10‘2 2.01-102 7.53-10'2
5.40-10 '2 1.7I-10'2 8.12-102
5.10-102 2.14-10 '2 8.28-102
x=5.08-102 x=1.93-102 x= 7.8710 '2
Sx=0.28-10‘2 S,=0.17-10'2 S,=0.32-10'2
x =  m e a n  v a lu e , S* =  m e a n  s ta n d a rd  d e v ia t io n ,  t0.i>5 -  c o n f id e n c e  lev e l
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CONCLUSIONS
It w as found  that all pharm aceu tica ls  under 
ex am ination  w ere co n tam in a ted  w ith Z H . T he co n ­
tent o f  th is im purity  in in jec tions an d  tab le ts  m an u ­
factured  in P o land  w as sim ila r to those o f  im p o rted  
tab le ts (T able  1). H aloperido l substance  and drops 
co n ta ined  Z H  in h ig h er con cen tra tio n s as com p ared  
to o th er d rug  fo rm s un d er ex am ination . H ow ever, 
these d ifferences a re  not sign ifican t as they  are 
w ith in  the p erm issib le  lim its (3, 4). T h e  o bserved  
d ifferences shall be assigned  to  quality  o f  original 
substance used  fo r p repara tion  o f  g iven  drug  form .
T h e  sig n ifican t d iffe re n ce s  in Z H  co n ten ts  
w ere fo u n d  in d ro p s  d irec tly  a n a ly sed  and  a fte r 
p re lim in a ry  Z H  sep a ra tio n  by  ex trac tio n . T h e  re­
su lts o b ta in ed  w ith  c h lo ro fo rm  e x trac tio n  a re  qu ite  
d iffe ren t to th o se  o f  d irec t d e te rm in a tio n . T h is  cas ts  
d o u b ts on  th e  re liab ility  and  accu racy  o f  the  resu lts  
o b ta in ed  by  ex trac tio n  m eth o d s fo r p re lim in a ry  ZH  
sep ara tio n . T h e  re su lts  p re sen te d  in  T ab le  3 p rov ide  
an e v id en ce  fo r d irec t d e te rm in a tio n  o f  Z H .
T h e  tes ts  w e ca rried  ou t c lea rly  in d ica te  that 
the  n ew ly  d e v e lo p ed  ch ro m a to g rap h ic  an d  den- 
sito m etric  m eth o d  can  be u sefu l fo r id en tifica tio n  
and d e te rm in a tio n  o f  Z H  im p u ritie s  in  v a rio u s d ru g  
form s. N o  p re lim in a ry  e x tra c tio n  is req u ired  un d er 
sp ec ified  c o n d itio n s, s in ce  c h ro m a to g rap h ic  sep a­
ration  and  p ro p o sed  d e tec tio n  m eth o d  e lim in a te  an 
e ffec t o f  the  co n co m itan t su b s tan ces on  th e  resu lts  
o f  d e te rm in a tio n .
T h e  re su lts  o f  sta tis tica l an a ly sis  p re sen ted  in 
T ab le  1 and  F ig u res 1 to  3 hav e  re v ea le d  th e  h igh  
sen sitiv ity , g o o d  p rec is io n , rep ea tab ility  and  a c ­
cu racy  o f  th e  new  m ethod .
F in a lly , it sh o u ld  be n o ted  th a t the  n ew ly  d ev e lo p ed  
m eth o d  fo r d e te rm in a tio n  o f  Z H  can  be u sed  in 
ro u tin e  ana ly sis  fo r d rug  p u rity  a sse ssm en t d u e  to  
its sim p lic ity  and  h ig h  accu racy  th a t g u aran tees 
re liab le  resu lts .
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